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Abstract. Hepatocellular carcinoma is the most frequent 
liver cancer and hepatitis Β virus is included among the risk 
factors for the development of this type of neoplasia. Direct 
detection of this virus is difficult due to the lack of a simple 
tissue culture system for growing the virus. Amplification of 
HBV nucleic acid sequences with the Polymerase Chain 
Reaction technique leads to the direct detection of the virus, 
but involves several critical steps and it is prone to false 
positive results due to inter sample contaminations. We 
overcame these shortcomings by using a simple boiling 
method for extracting DNA from histological slides of 
tissues coupled with double ('nested') PCR amplification. In 
this study we evaluated the frequency of presence of HBV 
nucleic acid sequences in samples of neoplastic liver tissues 
from patients in Greece. We studied 20 DNA samples from 
hepatocellular carcinomas and we found 11 positive for HBV 
DNA and 8 DNA samples from hepatoblastomas and we 
found 3 positive for the viral DNA. 
Introduction 
Hepatocellular carcinoma (HCC) is the most frequent liver 
cancer. Hepatitis Β virus (HBV) and aflatoxins are risk factors 
for HCC (1), but the molecular mechanism of human 
hepatocellular carcinogenesis is largely unknown. Hepatitis Β 
virus infection causes either acute or chronic hepatitis and usually 
is diagnosed after finding the hepatitis Β surface antigen 
(HBsAg) in serum. Normally infection is associated with the 
production of large amount of viral antigen that is readily 
detected in the serum. However, not all of the HBsAg in serum 
represents intact virions because the majority of this antigen 
consists of HBsAg particles produced in great excess of complete 
HBV particles. Direct detection of HBV is difficult due to the 
lack of a simple tissue culture system for growing the virus. 
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Molecular techniques including dot-blot hybridization using 
recombinant radiolabeled DNA have been employed for the 
detection of HBV DNA in tissue and serum specimens (2,3). 
The Polymerase Chain Reaction (PCR) is an in-vitro 
method for the primer directed enzymatic amplification of 
specific DNA sequences (4). Amplification of HBV nucleic 
acid sequences with this technique leads to a powerful 
method for the detection of the virus during acute or chronic 
HBV infection (5). 
Although this method of HBV detection is extremely 
sensitive it involves several critical steps and is prone to false 
positive results due to inter sample contaminations. We 
overcame the shortcomings of the standard PCR method by 
using a simple boiling method for extracting DNA from 
histological slides of tissues (6) coupled with double PCR 
amplification, agarose gel electrophoresis and ethidium 
bromide (EB) staining for the detection of specific HBV 
DNA sequences (7). 
This sensitive method, connected with the feasibility 
of polymerase chain reaction amplification of DNA in 
formalin-fixed and paraffin-embedded tissues, prompted 
us to evaluate the frequency of HBV nucleic acid 
sequences present in samples of liver tissues from 
patients in Greece with hepatocellular carcinomas and 
hepatoblastomas in order to establish a possible 
correlation. 
Methods 
DNA samples. DNA from histological slides of tissues 
from hepatocellular carcinomas and hepatoblastomas, 
fixed by formol and embedded in paraffin, was extracted 
by boiling in a lysis mixture after the dissolution of 
paraffin in chloroform (6). 
Slices of paraffin with no embedded tissues, empty 
vials and normal lymphocytes were processed together 
with the DNA specimens and used as negative tests for 
PCR amplification and the presence of HBV nucleic acid 
sequences. 
DNA extracted by the simplified guanidium method 
(8) from peripheral lymphocytes was used as a negative 
control. 
Oligonucleotide primers. The oligodeoxynucleotides 
were synthesized by the solid phase triester method in an 
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Applied Biosystems DNA synthesizer. The primers were 
designed to amplify a specific region of the HBV 
genome. 
Primer 1763 (5' GCT TGG GGG CAT GGA CAT 
TGA CCC GTA TAA 3') begins at map position 1763 of 
the HBV genome (9). Primer 2032R (5' CTG ACT ACT AAT 
TCC CTG GAT GCT GGG TCT 3') from the complementary or 
reverse strand begins at map position 2032. Primer 1778 (5' GAC 
GAA TTC CAT TGA CCC GTA TAA AGA ATT 3') begins at 
map position 1778 and primer 2017R (5' ATG GGA TCC CTG 
GAT GCT GGG TCT TCC AAA 3') begins at map position 2017. 
The position of these primers in the viral genome is depicted in 
Fig. 1. 
WWWi =Enhancer 
Figure 1. The organization of the HBV genome: 
0 denotes the positions of primers used for the PCR amplifications. 
The diagram is adapted from Schröder et al (I). 
Polymerase chain reaction. In-vitro enzymatic DNA 
amplification (PCR) was performed on an automated apparatus 
(DNA thermal Cycler from Perkin Elmer Cetus). 
We performed 35 cycles of amplification using primers 1763 
and 2032R. Each cycle includes 3 steps: (i) Denaturation of DNA 
at 94°C for 20 sec. (ii) Annealing of the primers at 42°C for 30 
sec. (iii) Enzymatic extension at 72°C for 1 min. For 
reamplification of the samples a 10 μΐ aliquot of the PCR was 
amplified as described above using primers 1778 and 2017R. 
The PCR products were analyzed by electrophoresis on 
LMP agarose gels and visualized by ultraviolet light 
Figure 2. Electrophoresis of PCR products: 
DNA from histological slides of tissues fromhepatocellularcarcinomas and 
hepatoblastomas were amplified by PCR (35 cycles) using the primers 1763 
and 2032R. A 10 μΐ aliquot of the PCR was reamplified using primers 1778 
and 2017R. 20 μΐ of the reamplified samples were electrophoresed on a 3% 
NuSieve agarose gel. 
Lane A: 2μg of the ΦΧ 174/Hae III molecular weight marker. 
Lane B: This sample is negative for HBV DNA (-). 
Lane C: This sample is weakly positive for HBV DNA (+). 
Lane D: This sample is strongly positive for HBV DNA (++). 
fluorescence after staining with EB (Fig.2). 
When a visible DNA band corresponding to the expected 
size (i.e. 270bp) was demonstrated in the product of the first 
PCR reaction the sample was classed as strongly positive for 
HBV DNA (++). When a visible DNA band corresponding 
to the expected size (i.e. 258bp) was found in the product of 
the reamplification the sample was classed as weakly 
positive for HBV DNA ( + ). Samples which did not 
demonstrate a visible band even after reamplification were 
classed as negative for HBV DNA (-). 
HBsAg staining. Orcein staining for the hepatitis Β surface 
antigen was performed as previously described (10). 
Results and Discussion 
We used the above technique to detect the presence of 
HBV nucleic acid sequences in cell populations from 
formalin-fixed and paraffin-embedded liver tissues from 
patients with hepatocellular carcinomas and 
hepatoblastomas. 
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Table I. Hepatitis Β virus DNA in hepatocellular carcinomas. 
Patient 
N° 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Age 
(years) 
60 
55 
55 
69 
47 
75 
56 
59 
52 
74 
65 
93 
65 
75 
76 
68 
63 
9 
Sex 
M 
M 
M 
M 
F 
M 
F 
M 
M 
M 
M 
F 
M 
M 
M 
F 
M 
M 
M 
M 
Histological 
type 
Trab. 
Trab. + Sol. 
Tub. 
Trab. + Tub. 
Trab. 
Tub. 
Sol. 
Trab. 
Trab. 
Trab. 
Trab. + Dif. 
Trab. + Dif. 
Trab. + Sol. 
Trab. + Tub. 
Trab. 
Trab. 
Trab. + Sol. 
Trab. + Tub. 
Trab. + Sol. 
Sol. + Tub. 
Degree of 
differentiation 
High 
Poor 
Moderate 
Moderate 
High 
Moderate 
Moderate 
High 
Poor 
High 
Moderate 
Poor 
Poor 
High 
Moderate 
High 
Poor 
Poor 
Moderate 
Moderate 
Liver 
cirrhosis 
No 
Yes 
Unknown 
Yes 
Yes 
No 
No 
Yes 
Yes 
No 
No 
Unknown 
No 
No 
Yes 
Yes 
Yes 
No 
No 
Yes 
HBV, 
DNAD 
+ 
++ 
+ 
+ 
-
-
+ 
+ 
-
-
+ 
-
-
-
+ 
-
-
+ 
+ 
+ 
HBsAg 
staining 
-
++ 
Unknown 
-
-
-
-
-
Unknown 
-
-
-
-
-
+ 
-
-
-
-
++ 
a. Trab.=Trabecular, Tub.=Tubular, Sol.=Solid, Dif.=Diffuse 
b. The HBV DNA detected by PCR was judged as strongly positive (++) or weakly positive (+) after detection by a single or 
double PCR amplification respectively. 
Table II. Hepatitis Β virus DNA in hepatoblastomas. 
Patient Age 
N° (years) 
Histological type HBV 
DNA a 
HBsAg 
staining 
2 
3 
4 
5 
6 
7 
28 days 
3 
2 
3 
11 months 
4 months 
Mixed type: fetal epithelial component + 
mesenchyma with osteoid stroma 
pure fetal type 
pure fetal type 
Epithelial (fetal + embryonal component) 
Mixed type: fetal embryonal epithelial 
component + osteoid stroma 
Mixed type: embryonal + epithelial 
components and mesenchyma with osteoid 
pure fetal type 
Mixed type: fetal embryonal epithelial 
component + osteoid 
++ 
Unknown 
Unknown 
Unknown 
Unknown 
a. as b in Table I 
We studied 20 DNA samples from patients with 
hepatocellular carcinomas, and we found 1 1 samples 
positive for HBV DNA and 8 DNA samples from patients 
with hepatoblastomas and we found 3 samples positive for 
this DNA. These results are presented in Tables I and II. 
Analyzing further these experimental data we arrive at 
the following conclusions: 
The PCR method for HBV DNA detection is significantly 
more sensitive compared to the orcein stain because it picks 
up positive cases which are negative for HBsAg staining. 
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Seven out of ten positive cases of hepatocellular carcinomas 
for HBV DNA appear negative for HBsAg with orcein stain. 
The case No 3 is marked unknown because no tissue was 
available for orcein stain since the biopsy block was small 
and the whole t issue was used for D N A extract ion. In 
addition there is no case which is positive for HBsAg and 
negative for HBV DNA. The HBV DNA is incorporated in to 
the nuclei of tumor cells since cases 3,7,18 and 19 contained 
exclusively tumor tissues. It has to be noted that the HBsAg 
positive cells belonged to the normal liver cells from adjacent 
areas of the hepatic parenchyma and not to tumor cells which 
appear negative for HBsAg in all studied cases. 
Hepatoblastomas are not associated with HBV infection 
and yet three out of eight cases gave positive results for HBV 
D N A . In addi t ion these three pos i t ive cases appeared 
negative for HBsAg although the stained sections contained 
both tumor and adjacent areas of normal hepatic parenchyma. 
These findings can be explained theoretically in two 
ways: these three cases are false positive cases which cannot 
be considered because in our study we used negative and 
p o s i t i v e c o n t r o l s d u r i n g all the s tages of s a m p l e s 
manipulation, or these three patients are carriers of hepatitis 
Β infected probably during birth from their mothers and the 
a s s o c i a t i o n of the p r e s e n c e of H B V D N A with 
hepatoblastomas is just accidental. 
The fact that these three patients are negative for HBsAg 
with orcein stain can be explained. Positivity for HBsAg 
requires chronicity of infection and as we can see in case two 
which gave the strongest positivity the infant is only 28 days 
old. Unfortunately the age of the other two positive patients 
is not available although hepatoblastomas do not occur in 
children older than three years. 
Definitive correlations between the presence of HBV 
DNA and these forms of liver neoplasias could be established 
only after a large study of patients using this sensitive 
method of detection in DNA samples extracted by a standard 
protocol. 
Finally, this philosophy will permit to correlate clinical 
information about the cancer and stages of HBV infection 
with data from histology and molecular biology in these 
interesting cases of liver carcinogenesis. 
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